This occurs through the promotion of EMT, enabling cancer cells to migrate and invade adjacent tissues, modulation of immune responses by inhibiting CD8+T-cell function and encouraging macrophage differentiation into an M2 phenotype that supports tumor growth, as well as stimulating angiogenesis and extracellular matrix remodeling that aid in tumor progression (Table 1). Here, CD8A is linked to neoplasm.